key: cord-0255507-fms14iqc authors: Schmidt, T.; Kahn, R.; Kahn, F. title: Ascorbic acid attenuates activation and cytokine production in sepsis-like monocytes date: 2021-04-20 journal: nan DOI: 10.1101/2021.04.15.21255504 sha: 0d2ef102e0ec9a0f689598cae10bb37c6059b6a1 doc_id: 255507 cord_uid: fms14iqc Objective To investigate the effects of high dose ascorbic acid (AA) on monocyte polarization and cytokine production in vitro Design Experimental in vitro study of cells from healthy subjects and patients with sepsis Setting University research laboratory and academic hospital Subjects Six healthy controls and three patients with sepsis Interventions Monocytes were isolated from whole blood of healthy donors (n=6) and polarized in vitro for 48hrs using LPS or LTA. Polarization was confirmed by surface marker expression using flow cytometry. As a comparison, monocytes were also isolated from septic patients (n=3) and analyzed for polarization markers. The effect of AA on monocyte polarization was evaluated. As a functional assay, AA-treated monocytes were analyzed for cytokine production of TNF and IL-8 by intracellular staining and flow cytometry following activation with LPS or LTA. Measurements and Main Results Both LPS and LTA induced polarization in healthy monocytes in vitro, with increased expression of both pro- (CD40 and PDL1, p<0.05) and anti-inflammatory (CD16 and CD163, p<0.05) polarization markers, with non-significant effects on CD86 and CD206. This pattern resembled, at least partly, that of monocytes from septic patients. Treatment with AA significantly inhibited the upregulation of surface expression of CD16 and CD163 (p<0.05) in a dose dependent manner, but not CD40 or PDL-1. Finally, AA attenuated LPS or LTA-induced cytokine production of IL-8 and TNF in a dose-dependent manner (both p<0.05). Conclusions AA inhibits upregulation of anti-, but not pro-inflammatory related markers in LPS or LTA polarized monocytes. Additionally, AA attenuates cytokine production from in vitro polarized monocytes, displaying functional involvement. This study provides important insight into the immunological effects of high dose AA on monocytes, and potential implications in sepsis. To investigate the effects of high dose ascorbic acid (AA) on monocyte polarization and cytokine production in vitro Design Experimental in vitro study of cells from healthy subjects and patients with sepsis Setting University research laboratory and academic hospital Six healthy controls and three patients with sepsis Monocytes were isolated from whole blood of healthy donors (n=6) and polarized in vitro for 48hrs using LPS or LTA. Polarization was confirmed by surface marker expression using flow cytometry. As a comparison, monocytes were also isolated from septic patients (n=3) and analyzed for polarization markers. The effect of AA on monocyte polarization was evaluated. As a functional assay, AA-treated monocytes were analyzed for cytokine production of TNF and IL-8 by intracellular staining and flow cytometry following activation with LPS or LTA. Both LPS and LTA induced polarization in healthy monocytes in vitro, with increased expression of both pro-(CD40 and PDL1, p<0.05) and anti-inflammatory (CD16 and CD163, p<0.05) polarization markers, with non-significant effects on CD86 and CD206. This pattern resembled, at least partly, that of monocytes from septic patients. Treatment with AA . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.15.21255504 doi: medRxiv preprint 3 significantly inhibited the upregulation of surface expression of CD16 and CD163 (p<0.05) in a dose dependent manner, but not CD40 or PDL-1. Finally, AA attenuated LPS or LTAinduced cytokine production of IL-8 and TNF in a dose-dependent manner (both p<0.05). AA inhibits upregulation of anti-, but not pro-inflammatory related markers in LPS or LTA polarized monocytes. Additionally, AA attenuates cytokine production from in vitro polarized monocytes, displaying functional involvement. This study provides important insight into the immunological effects of high dose AA on monocytes, and potential implications in sepsis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Sepsis occurs due to a dysregulated immune response to infection. Current treatments include anti-infective therapy and supportive care, but no treatment targeting the dysregulated immune system is in clinical use. High dose ascorbic acid (AA) /vitamin C has emerged as a potential treatment and has showed early promising results(1, 2). However, recent randomized controlled studies have failed to demonstrate a general benefit of AA treatment(3). Nonetheless, sepsis patients have low levels of AA and AA treatment is speculated to benefit multiple systems, e.g. the circulatory system(1). Yet, few studies have addressed the effects of AA on the immune response in sepsis. Monocytes are immune cells with important roles, such as cytokine production, antigen presentation and phagocytosis. In sepsis, monocytes are highly activated, or polarized, expressing markers related to scavenging (CD163), phagocytosis (CD16) and antigen presentation (CD40, PDL-1) (4) (5) (6) . Yet, it is important to note that conflicting data exists regarding surface markers in sepsis, likely reflect timing and subgroups of sepsis. Functionally, septic monocytes display a state of exhaustion with immunosuppressive features, increased ROS generation and intact or increased phagocytosis (7) . To the best of our knowledge, there has been no studies investigating the effects of AA on monocyte polarization. Here, we aimed to investigate the effects of high dose AA on monocyte polarization and function on in vitro polarized monocytes within the setting of sepsis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. First, we sought to explore the influence of two bacterial components, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), on monocyte polarization. Stimulation of healthy monocytes (n=6) resulted in significant upregulation of CD16, CD163, CD40 and PDL1 (p<0.05) upon 48hrs of LPS stimulation ( Figure 1A) . Histograms of a representative sample can be found in Supplemental Digital Content 2B. CD16, CD163 and PDL1 were upregulated following polarization with LTA (p<0.05) ( Figure 1B) . Expression of CD86 and CD206 was not significantly altered by LPS or LTA stimulation. However, there was a trend for elevated CD206 expression in LPS polarized monocytes. Thus, polarization could be induced by LPS or LTA. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.15.21255504 doi: medRxiv preprint Next, we sought to confirm previously described changes in monocyte surface marker expression. Monocytes from whole blood of septic patients (n=3) tended to have increased expression of both traditional anti-and pro-inflammatory markers such as CD16, CD163, CD40 and PDL1, and lower expression of CD86 and CD206 compared to healthy controls (n=3) (Figure 1C) . Hence, the expression pattern of the monocytes from the septic patients is comparable, at least partly, to LPS or LTA polarized monocytes in figure 1A . To investigate if ascorbic acid (AA) could modulate monocyte polarization, monocytes were stimulated with LPS or LTA, with and without supplemented AA. AA at 125µg/ml attenuated the expression of CD16 and CD163 in LPS or LTA polarized monocytes to that of the controls (Figure 1A Next, we investigated if the effects of AA are due to a downregulatory or inhibitory mechanism. Addition of AA to monocytes 24hrs after LPS or LTA stimulation, instead of at the start of culture, did not result in altered expression of CD16 and CD163 compared to monocytes not receiving AA (Supplemental Digital Content 6A-B) . Thus, AA inhibits upregulation-, rather than downregulates, the observed surface markers. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.15.21255504 doi: medRxiv preprint To investigate whether AA affected monocyte function, we assessed cytokine production of IL-8 and TNF in healthy monocytes (n=6). Both LPS and LTA induced production of IL-8 and TNF (Figure 2A-B) which was attenuated by AA (p<0.05) (Figure 2B-C) . This effect was also dose dependent ( Figure 2D) . Thus, AA affects monocytes on the functional level and inhibits production of IL-8 and TNF. In this study, we show that ascorbic acid (AA) attenuates lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced expression of CD16 and CD163, but not of CD40 and PDL-1, in monocytes from healthy controls. Furthermore, we show that AA influences monocyte function by inhibiting LPS and LTA induced production of IL-8 and TNF. Thus, monocytes polarized by bacterial components are functionally affected by AA, which provide important insight into the mechanisms of AA as a treatment in sepsis. AA has been suggested as treatment for multiple diseases, ranging from cancer to sepsis. Patients with sepsis display low levels of AA(1). Given the role of AA in the immune system, the evidence of ROS dysfunction in sepsis and a retrospective before-after study showing a major reduction in mortality within septic patients treated with high dose AA, a massive interest was sparked to use AA as a treatment for sepsis (2) . However, recently, several randomized control trials failed to demonstrate a general beneficial effect of AA in sepsis(3). Although, these studies did not thoroughly distinguish among different types of sepsis, pathogens or immunological states. Hence, AA might have potential in specific windows-of-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.15.21255504 doi: medRxiv preprint 8 time or in certain subgroups. It could be speculated that patients suffering from a more severe immune dysregulation could represent a group for AA treatment. Our observation that AA inhibits upregulation-, rather than downregulates the observed polarization markers is important in the aspect of future study designs. This data highlights the role of timing of AA treatment, and could be a potential factor contributing to the lack of benefit in the conducted studies. Septic monocytes have been shown to be activated as evidenced by increased expression of polarization markers such as CD16, CD163, PDL-1 and CD40, amongst others(4-6). However, results on expression of polarization markers are conflicting, likely reflecting timing and different phenotypes amongst patients. In this study, LPS or LTA polarized monocytes treated with AA displayed reduced expression of CD16 and CD163 in a dose dependent manner, but not of CD40 and PDL-1. Traditionally, CD16 and CD163 are markers of anti-inflammation, or M2, polarization and are upregulated by various stimulus in vitro, such as IL-10. These monocytes, or macrophages, have traditionally been termed suppressive. However, it is important to note the complexity of polarization. CD163 + monocytes produce more pro-inflammatory cytokines than CD163monocytes in sepsis (7). In addition, monocytes display a suppressive and exhausted phenotype and when exposed to LPS they respond poorly with production of pro-inflammatory cytokines, as opposed to monocytes from patients with hyperinflammatory COVID-19 (8) . Thus, these data suggest that AA might not target only the pro-inflammatory aspect (inflammatory cytokine production) but also the immunosuppressive phenotype (CD16 and CD163) of monocytes in sepsis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.15.21255504 doi: medRxiv preprint 9 Evidence exists for the potential role of AA in the immune system during sepsis. High dose AA has been shown to inhibit neutrophil NETosis, and mice lacking AA synthesis produced more NETs than control mice in a sepsis model (9) . Thus, we sought to determine whether AA affects other immune cells, i.e. monocytes. At the functional level, we found that both LPS and LTA induced IL-8 and TNF production, which was attenuated by AA in a dose dependent manner. Using a similar method, a previous study found that AA attenuates LPS induced production of IL-6 and TNF, but not IL-8 in monocytes in whole blood (10) . The use of whole blood, rather than purified monocytes, could be a major contribute to the discrepancy between our results. Nevertheless, we further confirm that AA influences monocytes function by inhibiting pro-inflammatory cytokine production. The use of LPS and LTA polarized monocytes as opposed to monocytes from patients with sepsis constitutes a limitation in this study. Even though LPS and LTA polarized monocytes display similarities with septic monocytes, the use of these cells would be important to explore in future studies. Furthermore, we could demonstrate that AA attenuates cytokine production, but to fully characterize the effects of AA on monocyte function more experiments must be made, studying other aspects of monocyte function, such as phagocytosis and ROS production. In conclusion, we show that high concentrations of AA attenuate LPS or LTA induced surface expression of CD16 and CD163, but not CD40 and PDL-1. Furthermore, AA inhibits LPS or LTA induced cytokine production of TNF and IL-8. These data provide an important insight into the effect of AA on monocytes in relation to sepsis. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. Statistics were performed using the Wilcoxon matched-pair signed rank test. *p<0.05. Supplemental Digital Content 1 Materials And Methods Provides the performed methods and measurements of this study. shows the gating strategy of a septic patient applied to analyze the expression of surface markers in monocytes in whole blood. (B) Shows representative histograms of the six analyzed surface markers in unstained -, control-and LPS stimulated monocytes following 48hrs of culture. Monocytes were isolated from healthy controls (n=3) and polarized with LPS and treated with AA at different concentrations for 48hrs. The control well received no AA treatment. Viability of monocytes was assessed in a dose dependent manner and analyzed using annexin V and propidium iodine (n=3) (B) AA at 125µg/ml slightly reduced the pH from 7.6 to 7.2 in medium. Restoration of pH was performed using NaHCO 3 as a buffer. In parallel, HCl was used to lower to pH of medium to 7.2 to mimic the effect of AA on pH. Monocytes were cultured for 48hrs and analyzed for expression of six activation markers by flow cytometry. Line at median. LPS -Lipopolysaccharide, AA -Ascorbic acid Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock A Retrospective Before-After Study Mortality in septic patients treated with vitamin C: a systematic meta-analysis Human Monocytes Undergo Functional Re-programming during Sepsis Mediated by Hypoxia-Inducible Factor-1 alpha Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study Monocyte CD40 expression in severe sepsis Modulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokines Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19 Vitamin C: A Novel Regulator of Neutrophil Extracellular Trap Formation Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Dr. Anki Mossberg and Dr. Birgitta Gullstrand are humbly acknowledged for their aid in handling of patient samples. We thank Sabine Arve-Butler, Olivia Aherne, Anki Mossberg and Louise Thelaus for their critical input on the manuscript. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.15.21255504 doi: medRxiv preprint